Natural killer cell function and interferon generation in patients with primary immunodeficiencies Journal Article


Authors: Messina, C.; Kirkpatrick, D.; Fitzgerald, P. A.; O'Reilly, R. J.; Siegal, F. P.; Cunningham-Rundles, C.; Blaese, M.; Oleske, J.; Pahwa, S.; Lopez, C.
Article Title: Natural killer cell function and interferon generation in patients with primary immunodeficiencies
Abstract: Patients with primary immunodeficiency disorders were evaluated for three aspects of natural defense: natural killer (NK) cells which lyse HSV-infected fibroblasts [NK(HSV-FS)], NK cells which lyse K562 tumor targets [NK(K562)], and interferon-α generation. In addition, capacity to make interferon upon challenge with other commonly used inducers was also evaluated. Most patients with severe combined immunodeficiency disease (SCID) and deficits of both T- and B-cell function demonstrated normal NK function with one or both targets. Six of eight SCID patients generated interferon-α at or below the lower limit of normal while only two made clearly normal levels. Six of 10 patients with Wiskott-Aldrich syndrome (WAS) had normal NK(K562) and five of 10 generated normal levels of interferon-α but all had severely deficient NK(HSV-FS). Patients with Bruton's agammaglobulinemia demonstrated normal NK and interferon generation, as did patients with common variable immunodeficiency, even when subdivided into patients with T-cell proliferative deficiencies and those with only hypogammaglobulinemia. Natural defense parameters may help categorize patients with SCID and WAS and help define these heterogeneous diseases. © 1986.
Keywords: clinical article; interferon; natural killer cell; killer cells, natural; combined immunodeficiency; immunologic deficiency syndromes; immunity, cellular; etiology; interferon type i; wiskott aldrich syndrome; immunity, natural; wiskott-aldrich syndrome; humans; human; priority journal; agammaglobulinemia; blood and hemopoietic system
Journal Title: Clinical Immunology and Immunopathology
Volume: 39
Issue: 3
ISSN: 0090-1229
Publisher: Elsevier Inc.  
Date Published: 1986-06-01
Start Page: 394
End Page: 404
Language: English
DOI: 10.1016/0090-1229(86)90167-4
PUBMED: 3698344
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 18 August 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard O'Reilly
    747 O'Reilly